Gene-environment interplay between cannabis and psychosis.

Schizophrenia Bulletin
Cécile HenquetRobin M Murray

Abstract

Cannabis use is considered a contributory cause of schizophrenia and psychotic illness. However, only a small proportion of cannabis users develop psychosis. This can partly be explained by the amount and duration of the consumption of cannabis and by its strength but also by the age at which individuals are first exposed to cannabis. Genetic factors, in particular, are likely to play a role in the short- and the long-term effects cannabis may have on psychosis outcome. This review will therefore consider the interplay between genes and exposure to cannabis in the development of psychotic symptoms and schizophrenia. Studies using genetic, epidemiological, experimental, and observational techniques will be discussed to investigate gene-environment correlation gene-environment interaction, and higher order interactions within the cannabis-psychosis association. Evidence suggests that mechanisms of gene-environment interaction are likely to underlie the association between cannabis and psychosis. In this respect, multiple variations within multiple genes--rather than single genetic polymorphisms--together with other environmental factors (eg, stress) may interact with cannabis to increase the risk of psychosis. Further research on...Continue Reading

References

Feb 1, 1992·Acta Psychiatrica Scandinavica·V Peralta, M J Cuesta
Sep 1, 1991·British Journal of Addiction·H R ChaudryT Suliman
Jan 1, 1991·Psychiatry Research·K S KendlerA F Mirsky
Nov 21, 1990·JAMA : the Journal of the American Medical Association·D A RegierF K Goodwin
Jan 1, 1990·Schizophrenia Bulletin·K T MueserK G Yadalam
Sep 1, 1987·The Journal of Nervous and Mental Disease·M Csikszentmihalyi, R Larson
Jan 1, 1974·Archives of General Psychiatry·G S Chopra, J W Smith
Jan 1, 1967·Psychopharmacologia·H IsbellF Korte
Oct 13, 1969·JAMA : the Journal of the American Medical Association·J A Talbott, J W Teague
Aug 20, 1996·Proceedings of the National Academy of Sciences of the United States of America·M LaruelleR B Innis
Dec 12, 1997·Acta Psychiatrica Scandinavica·J Addington, V Duchak
Oct 27, 1998·The Journal of Nervous and Mental Disease·A HonigM W deVries
Nov 18, 1998·Archives of General Psychiatry·K R MerikangasB J Rounsaville
Apr 9, 1999·European Archives of Psychiatry and Clinical Neuroscience·D Caspari
May 17, 2000·American Journal of Medical Genetics·W J Chen, S V Faraone
Feb 15, 2001·Drug and Alcohol Dependence·D R MilesR W Pickens
Feb 24, 2001·Schizophrenia Bulletin·A W MacDonaldS Manuck
Apr 17, 2001·American Journal of Medical Genetics·L KrabbendamJ van Os
Jun 8, 2001·Proceedings of the National Academy of Sciences of the United States of America·M F EganD R Weinberger
Sep 22, 2001·Psychiatry Research·L N VorugantiA G Awad
Dec 26, 2001·Archives of General Psychiatry·I Myin-GermeysP A Delespaul
Aug 16, 2002·American Journal of Epidemiology·J van OsH Verdoux
Sep 19, 2002·Molecular Pharmacology·Sophie Parmentier-BatteurDavid A Greenberg
Nov 26, 2002·BMJ : British Medical Journal·Louise ArseneaultTerrie E Moffitt
Jan 23, 2003·Psychological Medicine·D M FergussonN R Swain-Campbell
Apr 2, 2003·The American Journal of Psychiatry·Irving I Gottesman, Todd D Gould
Apr 16, 2003·Schizophrenia Bulletin·Catherine SpencerPatricia T Michie
Feb 3, 2004·The British Journal of Psychiatry : the Journal of Mental Science·Louise ArseneaultRobin M Murray
May 18, 2004·Nature Neuroscience·Susana MatoOlivier J Manzoni
Aug 12, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Robert M BilderAnthony A Grace

❮ Previous
Next ❯

Citations

Jul 18, 2009·European Archives of Psychiatry and Clinical Neuroscience·Deepak Cyril D'SouzaMohini Ranganathan
Feb 19, 2011·European Archives of Psychiatry and Clinical Neuroscience·A Carlo AltamuraBernardo Dell'Osso
Dec 22, 2009·European Child & Adolescent Psychiatry·Anne-Kathrin WermterKatja Becker
Jul 3, 2013·Asian Journal of Psychiatry·Preeti Parakh, Debasish Basu
May 12, 2011·Psychological Medicine·J E HoustonG Adamson
Sep 17, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Tyler A LeshCameron S Carter
Mar 11, 2009·Schizophrenia Bulletin·John J McGrath, Linda J Richards
Jul 28, 2009·Schizophrenia Bulletin·Stephan Heckers
Sep 29, 2009·Schizophrenia Bulletin·Bart P F Rutten, Jonathan Mill
May 16, 2013·BMC Medicine·Ian B HickiePatrick D McGorry
Jul 10, 2010·Substance Abuse Treatment, Prevention, and Policy·Chaturaka RodrigoSenaka Rajapakse
Dec 14, 2012·Genome Medicine·Masaki NishiokaKazuya Iwamoto
Jul 1, 2009·Indian Journal of Psychological Medicine·Chaturaka Rodrigo, Senaka Rajapakse
Sep 24, 2013·Neurobiology of Learning and Memory·Christine A RabinakK Luan Phan
Feb 12, 2014·Progress in Neuro-psychopharmacology & Biological Psychiatry·Rassil Ghazzaoui, Anissa Abi-Dargham
Jun 12, 2013·Neurobiology of Disease·Geetha KannanMikhail V Pletnikov
Mar 3, 2010·Annual Review of Clinical Psychology·Emma Barkus, Robin M Murray
Jun 25, 2014·Molecular Psychiatry·R A PowerN G Martin
Dec 26, 2013·Psychosomatics·Amir GarakaniDavid M McDowell
Jun 2, 2010·The British Journal of Psychiatry : the Journal of Mental Science·Cécile HenquetInez Myin-Germeys
May 15, 2009·Journal of Clinical Psychopharmacology·Glenn SchwarczRichard McCarthy
Aug 26, 2010·Pharmaceuticals·Marco BortolatoSimone Tambaro
Dec 3, 2014·Pharmacology & Therapeutics·Dan I LubmanMurat Yücel
Sep 10, 2013·Child and Adolescent Psychiatric Clinics of North America·Danielle Goerke, Sanjiv Kumra
Jul 9, 2013·Biological Psychiatry·Lisa-Marie GreenwoodNadia Solowij
Feb 1, 2012·Biological Psychiatry·Nina B L UrbanAnissa Abi-Dargham
Jun 15, 2011·Progress in Neurobiology·Viola Oertel-KnöchelHarald Hampel
Jul 13, 2011·Schizophrenia Research·Rebecca KuepperJim van Os
Apr 19, 2011·Schizophrenia Research·Benno G SchimmelmannMartin Lambert
Mar 11, 2010·Journal of the American Academy of Child and Adolescent Psychiatry·Stephen R HooperJeffrey A Lieberman
Sep 16, 2010·Schizophrenia Research·Mario MüllerAnita Riecher-Rössler
Apr 7, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·Amaya BustoJames L Kennedy
Oct 28, 2009·Progress in Neurobiology·Urs Meyer, Joram Feldon
Mar 28, 2009·European Psychiatry : the Journal of the Association of European Psychiatrists·Gisela SugranyesMiquel Bernardo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.